Control Bionics Ltd. (AU:CBL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Control Bionics Limited has successfully raised $2.68 million in capital through a combination of a Non-Renounceable Rights Issue and a placement. The company issued approximately 16.4 million shares, with the Rights Issue contributing $1.53 million and the placement adding $1.15 million. This financial boost is set to support Control Bionics’ innovative medical device technologies, including their NeuroNode and newly launched NeuroStrip.
For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.